Literature DB >> 1762291

Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.

C H Hsu1, R Vanholder, S Patel, R R De Smet, P Sandra, S M Ringoir.   

Abstract

Previous study from our laboratory has demonstrated that uremic plasma ultrafiltrate suppresses both the production rate (PR) and metabolic clearance rate (MCR) of calcitriol in normal rats. To characterize the the substances responsible for the suppression of the synthesis and degradation of calcitriol, we fractionated 20 ml uremic plasma ultrafiltrates into 13 fractions using high-performance liquid chromatography (HPLC) and studied the effect of each fraction on calcitriol metabolism. We measured the MCR and PR of calcitriol in normal rats after they were infused for 20 hours with each fraction dissolved in 20 ml normal saline. Using a UV absorption and fluorescence emission technique, several known uremic compounds were identified as individual peaks corresponding to the fractions. We found that fractions 4, and 6 to 13 markedly reduced the MCR of calcitriol. The patterns of the MCR suppression by the HPLC fractions suggest that there were at least two groups of chemically distinguishable compounds. Infusion of a solution containing all 13 fractions of the uremic ultrafiltrate also inhibited the calcitriol synthesis. One of the 13 fractions (fraction 4, containing uric acid, xanthine, and hypoxanthine) was further fractionated into eight subfractions. Infusion of subfractions 4 to 7 markedly reduced both the PR and MCR of calcitriol. We conclude that uremic plasma ultrafiltrate contains factors that inhibit calcitriol synthesis and degradation. These substances have molecular weight less than 2,000 Daltons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762291     DOI: 10.1038/ki.1991.287

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Authors:  Sagar U Nigwekar; Hector Tamez; Ravi I Thadhani
Journal:  Bonekey Rep       Date:  2014-02-05

Review 2.  Factors influencing drug protein binding in patients with end stage renal failure.

Authors:  R Vanholder; R De Smet; S Ringoir
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 3.  Vitamin D: metabolism.

Authors:  Sylvia Christakos; Dare V Ajibade; Puneet Dhawan; Adam J Fechner; Leila J Mady
Journal:  Endocrinol Metab Clin North Am       Date:  2010-06       Impact factor: 4.741

4.  The relationship between ultraviolet light exposure and mortality in dialysis patients.

Authors:  Bryan B Shapiro; Elani Streja; Joline L T Chen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Am J Nephrol       Date:  2014-10-11       Impact factor: 3.754

5.  Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

Authors:  S R Patel; H Q Ke; R Vanholder; R J Koenig; C H Hsu
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 6.  Current evidence on vitamin D deficiency and kidney transplant: What's new?

Authors:  Gerardo Sarno; Riccardo Nappi; Barbara Altieri; Giacomo Tirabassi; Emanuele Muscogiuri; Gianmaria Salvio; Stavroula A Paschou; Aristide Ferrara; Enrico Russo; Daniela Vicedomini; Cerbone Vincenzo; Andromachi Vryonidou; Silvia Della Casa; Giancarlo Balercia; Francesco Orio; Paride De Rosa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.